Events 2019-05-01T20:42:27+00:00

Where will Catalyst be speaking next?


FDA in the Post-Gottlieb Era: Catalyst to Offer Insights at Rising Leaders Conference
May 22, 2019
What will FDA regulation look like in the post-Gottlieb era? Now that Acting Commissioner Ned Sharpless is in place, what’s in store for the agency and innovators? Join us as Catalyst President Nancy Bradish Myers speaks on the future of FDA during the Coalition for Healthcare Communication’s Rising Leaders Conference on Healthcare Policy on May 22 in Washington, DC.


Digital Health Regulation: Catalyst to Moderate Panel at DIA Annual Meeting in San Diego
June 24, 2019
Catalyst President Nancy Bradish Myers will lead a panel discussion on “Hot Topics in Digital Health: How is FDA’s Approach Evolving, and What Do Industry and Patients Need to Know?” on June 24th during the DIA Annual Meeting in San Diego.

Join us for a wide-ranging, interactive discussion exploring FDA’s evolving approach to regulation of digital health technologies and how these policies may impact patients and innovators. Are these initiatives sufficient to facilitate innovation, or are there additional areas in which FDA could engage in order to help achieve this goal?

Panelists will include:

  • Katie Kopil, Director, Research Partnerships, Michael J. Fox Foundation
  • Yarmela Pavlovic, Partner, Hogan Lovells
  • Jacqueline Corrigan-Curay, Director, Office of Medical Policy, CDER, FDA

Where has Catalyst spoken recently?


“FDA Basics: Structure, Authorities & Hot Topics”
Presenter, Nancy Bradish Myers – Washington, DC
April 12, 2019 — University of Tennessee: Executive MBA Program (The Washington Campus)


Changes in the Political Landscape Impacting Pharma and Bio Regulations
Panelist, Nancy Bradish Myers – Washington, DC
December 2018 – FDA/CMS Summit


“2018 Policy Mash-Up: New Shifts in the Healthcare Market and What They May Mean for Patients and the Biopharma Industry”
Moderator, Nancy Bradish Myers – Boston
June 2018 – DIA 2018 Annual Meeting


“Real-World Evidence (RWE) in drug development”
Panelist, Nancy Bradish Myers – Beijing, China
May 2018 – 10th DIA China Annual Meeting


“The impact of new leadership and new initiatives at FDA”
Panelist, Nancy Bradish Myers — San Francisco
January 2018 — Biotech Showcase


“Regulating the Digital Health Revolution: When does it help or hinder innovation?”
Panelist, Nancy Bradish Myers — San Francisco
January 2018 — Digital Medicine & Medtech Showcase


“CRISPR – Regulatory Challenges in the Gene Editing Revolution”
Moderator/presenter Nancy Bradish Myers (panel) — Chicago
June 2017 — DIA 2017 annual meeting


 “Regulatory Frameworks: How Can Regulators Facilitate Disruptive Innovation?”
Moderator/presenter Nancy Bradish Myers (panel) — Chicago
June 2017 — DIA 2017 annual meeting


Keynote speech on FDA and the Trump Administration
Nancy Bradish Myers, Florham Park, NJ
May 2017: RxAdherence 2017, Strategies to Improve Outcomes conference


 “The Trump Administration – What to Expect From the FDA”
Panelist, Nancy Bradish Myers — San Francisco
January 2017: Biotech Showcase annual meeting


 “The Future of Big Data”
Moderator/presenter, Nancy Bradish Myers — Philadelphia
June 2016: DIA 2016 annual meeting — Panel, DIAmond Session

For a full list of Catalyst speaking engagements over the past few years, please see our Events Archive.